Drug Profile
Research programme: stem cell therapies - Stem Cell Sciences KK
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Stem Cell Sciences KK
- Class
- Mechanism of Action Cell replacements; Pancreatic beta cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus; Stress incontinence
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetes-mellitus in Japan (Injection, Implant)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Stress-incontinence in Japan (Injection, Implant)
- 28 Feb 2007 Preclinical trials in Diabetes mellitus in Japan (Implant)